| Date Filed | Type | Description |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 10,490 shares
@ $0.5993, valued at
$6.3k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 11/20/2020 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 10,665 shares
@ $0.4061, valued at
$4.3k
|
|
| 08/20/2020 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 10,929 shares
@ $0.8741, valued at
$9.6k
|
|
| 05/20/2020 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 9,913 shares
@ $0.5601, valued at
$5.6k
|
|
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2019 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 10,477 shares
@ $1.0611, valued at
$11.1k
|
|
| 05/22/2019 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 11,184 shares
@ $1.7292, valued at
$19.3k
|
|
| 03/22/2019 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 13,292 shares
@ $2.267, valued at
$30.1k
|
|
| 03/12/2019 |
4/A
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Exercised 27,822 restricted stock units
@ $0 |
|
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2018 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Granted 166,934 options to buy
@ $2.83, valued at
$472.4k
Granted 83,467 restricted stock units
@ $0 |
|
| 02/14/2018 |
5
| CARLO DENNIS J PHD (President & CEO) has filed a Form 5 on Adamis Pharmaceuticals Corp |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 02/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/27/2015 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Granted 232,103 options to buy
@ $5.99, valued at
$1.4M
|
|
| 04/03/2014 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Granted 45,200 options to buy
@ $6.32, valued at
$285.7k
Granted 90,300 options to buy
@ $6.32, valued at
$570.7k
|
|
| 03/12/2013 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Granted 124,378 shares
@ $0
Granted 111,828 shares
@ $0
Granted 535,982 options to buy
@ $0.67, valued at
$359.1k
|
|
| 07/25/2012 |
5
| CARLO DENNIS J PHD (President & CEO) has filed a Form 5 on Adamis Pharmaceuticals Corp |
| 09/15/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/10/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/13/2009 |
3
| CARLO DENNIS J PHD (President/CEO) has filed a Form 3 on Adamis Pharmaceuticals Corp |
| 05/01/1997 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/25/1997 |
SC 13D
| CARLO DENNIS J PHD reports a 5.7% stake in THE IMMUNE RESPONSE CORPORATION |